OUR NEWS - NETWORK

19
May

Two New Projects Successfully Authorized Within Seven Weeks Thanks to CATALIS QUEBEC’S FAST TRACK Evaluation Service

Two New Projects Successfully Authorized Within Seven Weeks Thanks to CATALIS QUEBEC’S FAST TRACK Evaluation Service   While the first-ever FAST TRACK evaluation service pilot project was successfully completed last December, CATALIS is proud to announce that two more clinical trials have now been approved in record time. The second FAST TRACK evaluation service coordinated a Phase I oncology study

Read more

16
Mar

CATALIS Quebec’s Network of Partners Now Includes 23 Quebec Health Institutions

CATALIS Quebec’s Network of Partners Now Includes 23 Quebec Health Institutions   In keeping with its new government mandate of bringing together clinical research stakeholders, CATALIS Quebec is pleased to announce that it is expanding the scope of its activities to a larger number of institutions in the province: it has added 23 public institutions from Quebec’s health and social

Read more

17
Dec

Three Major Projects Mark the Start of the Patient Advisory Committee’s Operations

Three Major Projects Mark the Start of the Patient Advisory Committee’s Operations   Patient partners and 11 patient organizations representing various medical conditions are at the core of CATALIS Quebec’s new Patient Advisory Committee. This committee was mandated by CATALIS management to identify common issues and solutions that will facilitate patient engagement and increase patient participation in, and referrals to, clinical

Read more

29
Nov

Patient Partners and 11 Patient Organizations Have Joined CATALIS Québec

Patient Partners and 11 Patient Organizations Have Joined CATALIS Québec   CATALIS Québec and its partners want the patient’s voice to be heard in all facets of clinical research in Quebec. As a result, we are now working with patient organizations and patient partners from various therapeutic fields by including them on our new patient advisory committee. In carrying out

Read more

16
Sep

CATALIS invites public institutions to join the network

CATALIS is launching a new call for applications to select public institutions that will receive 2 years of funding for their participation in CATALIS activities. Within the call for applications, public institutions that are members of the Table nationale des directeurs de recherche (TNDR) are invited to apply on 2 levels of clinical research activities: the implementation of automated tools

Read more

19
May

Boehringer Ingelheim and Sanofi Join the CATALIS Network

Boehringer Ingelheim and Sanofi Join the CATALIS Network New pharmaceutical industry partners are supporting CATALIS in making Quebec a world leader in clinical research. MONTREAL, May 20, 2021 —CATALIS Québec is proud to announce that two pharmaceutical companies, Boehringer Ingelheim and Sanofi, have joined its network of partners who are working together to support Quebec’s competitiveness in conducting clinical trials.

Read more

24
Feb

CATALIS Québec Partners with The Coolest Hotspot Initiative

Quebec is a top destination for life sciences and clinical research. To strengthen our efforts to spread this message beyond Quebec, CATALIS Québec has joined The Coolest Hotspot network.

10
Feb

A clinical trial to improve pancreatic cancer treatment

A team from the CHU de Québec-Université Laval has begun a clinical trial in order to develop new therapeutic options for the treatment of pancreatic adenocarcinoma, an aggressive cancer whose survival rate is less than one year.

5
Nov

Number of early-stage clinical studies at the CHU de Québec Research Centreabout to double

The CHU de Québec-Université Laval (CRCHU) Research Centre has worked extra hard this year to stimulate launches of early-stage clinical research projects in the Quebec City region. The Research Centre is about to double the number of clinical trials conducted in its institutions.

9
Oct

Discover the hematology/oncology clinical research team at the Hôpital de l’Enfant-Jésus in Quebec City

Clinical trials, cell therapies and partnerships with different specialities: the hematology/oncology research team at the Hôpital de l’Enfant-Jésus (HEJ) in Quebec City is involved in all areas where research can make a difference for its patients.

29
Aug

The CHUM Research Centre’s Unit for Innovative Therapies Officially Opens

On August 29th, the management team at the CHUM Research Centre officially opened its Unit for Innovative Therapies (UIT), a competitive infrastructure for early-stage clinical research in Canada.

3
Jun

Pharmaceutical Industry Invests in the Development of Early Clinical Research in Quebec

CATALIS’s public and private partners join forces to make Quebec a global leader in the conduct of early-stage clinical trials.

30
Apr

CATALIS and the McPeak-Sirois Group collaborate to promote the growth of clinical research in Quebec

The two organizations are joining forces to maximize the human and economic benefits of clinical trials province-wide.

6
Feb

Novartis and Roche join the CATALIS Initiative

Novartis and Roche Join the CATALIS Initiative Industry partnership will help establish Quebec as a global leader in early stage clinical research MONTREAL, February 6, 2019— The CATALIS initiative is proud to announce that pharmaceutical companies Novartis and Roche have joined its partner network. A mere two years after its creation, CATALIS Québec has succeeded in mobilizing Quebec’s key players

Read more

5
Jun

The CATALIS initiative celebrates new partners

The CATALIS initiative celebrates new partners Private and public funding provide essential support and highlight Quebec’s role in the field of early stage clinical trials BOSTON, June 5th, 2018 –  A year following its launch at the BIO conference in 2017, the CATALIS initiative is today proud to announce the arrival of new partners, both financial and medical, which will further

Read more

8
May

Merck Canada provides financial and expert support to CATALIS

Progression of Quebec’s world-class Early Clinical Research Ecosystem Merck Canada provides financial and expert support to CATALIS MONTREAL, Quebec (May 9, 2018) – CATALIS is proud to announce that Merck Canada confirms financial and expert support for its early clinical research initiative. This support from Merck Canada contributes to the promotion of this world-class field of research in Quebec. “At

Read more